why choose us

First received: September 20, 2023

Clinical Trial: Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma Multiforme

Study Type: OBSERVATIONAL


Official Title: Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients

Brief Summary: To learn how altered metabolism in GBM causes tumor growth and resistance to drug therapy.In this pilot research study, we will dose GBM patients with a form of nicotinamide (a natural vitamin) that we can track.The nicotinamide will be converted to methyl nicotinamide (MeNAM) in the tumor.We will measure how fast the nicotinamide is converted to methyl nicotinamide.We believe that the speed of this chemical reaction in the tumor (fast versus slow) may be correlated with GBM aggressiveness

Read more